Immunization

>

Latest News

Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine
Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine

May 10th 2024

While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.

COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose / image credit: ©New Africa/AdobeStock
COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose

April 30th 2024

Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone
Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone

April 22nd 2024

Influenza Vaccine Education in Emergency Departments Improves Uptake, According to New Study / Image credit: ©Tsuboya/AdobeStock
Influenza Vaccine Education in Emergency Departments Improves Uptake, According to New Study

March 29th 2024

©Kateryna_Kon/stock.adobe.com
Merck's 21-Valent Adult-Specific Pneumococcal Vaccine Accrues New Phase 3 and Real World Data

March 19th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.